EUVIMEDEUVIMED entdecken
LeitlinieSystematische Übersicht

Screening for Latent Tuberculosis Infection in Adults

US Preventive Services Task Force, Carol M Mangione, Michael J Barry, Wanda K Nicholson, Michael Cabana, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén, Li Li, Gbenga Ogedegbe und 5 weitere

JAMA · 02.05.2023 · 329 (17) · 1487

DOI: 10.1001/jama.2023.4899 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA, erschienen am 02.05.2023. Verfasst von US Preventive Services Task Force und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Los Angeles. Hauptthemen laut MEDLINE: Latent Tuberculosis. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance In the US, tuberculosis remains an important preventable disease, including active tuberculosis, which may be infectious, and latent tuberculosis infection (LTBI), which is asymptomatic and not infectious but can later progress to active disease. The precise prevalence rate of LTBI in the US is difficult to determine; however, estimated prevalence is about 5.0%, or up to 13 million persons. Incidence of tuberculosis varies by geography and living accommodations, suggesting an association with social determinants of health. Objective To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on LTBI screening and treatment in asymptomatic adults seen in primary care, as well as the accuracy of LTBI screening tests. Population Asymptomatic adults 18 years or older at increased risk for tuberculosis. Evidence Assessment The USPSTF concludes with moderate certainty that there is a moderate net benefit in preventing active tuberculosis disease by screening for LTBI in persons at increased risk for tuberculosis infection. Recommendation The USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Latent TuberculosisAdultHumansMass ScreeningRisk AssessmentTuberculosisUnited StatesSocial Determinants of Health

Autor:innen und Institutionen

  • University of California, Los Angeles.
  • Harvard Medical School, Boston, Massachusetts.
  • George Washington University, Washington, DC.
  • Albert Einstein College of Medicine, New York, New York.
  • Virginia Commonwealth University, Richmond.
  • University of Washington, Seattle.

Zitieren

APA

US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Li, L., Ogedegbe, G., Rao, G., Ruiz, J. M., Stevermer, J., Underwood, S. M., & Wong, J. B. (2023). Screening for Latent Tuberculosis Infection in Adults. JAMA, 329(17), 1487. https://doi.org/10.1001/jama.2023.4899

Vancouver

US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, et al. Screening for Latent Tuberculosis Infection in Adults. JAMA. 2023;329(17):1487. doi:10.1001/jama.2023.4899

BibTeX
@article{USPreventiveServicesTaskForce2023,
  author = {US Preventive Services Task Force, US Preventive Services Task Force and Mangione, Carol M and Barry, Michael J and Nicholson, Wanda K and Cabana, Michael and Chelmow, David and Coker, Tumaini Rucker and Davis, Esa M and Donahue, Katrina E and Jaén, Carlos Roberto and Li, Li and Ogedegbe, Gbenga and Rao, Goutham and Ruiz, John M and Stevermer, James and Underwood, Sandra Millon and Wong, John B},
  title = {Screening for Latent Tuberculosis Infection in Adults},
  journal = {JAMA},
  year = {2023},
  volume = {329},
  number = {17},
  pages = {1487},
  doi = {10.1001/jama.2023.4899}
}
Kostenlos starten →